XML 64 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SHAREHOLDERS' EQUITY (Details Textual)
 3 Months Ended 12 Months Ended
Mar. 15, 2024
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2015
$ / shares
Mar. 31, 2024
₪ / shares
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2023
₪ / shares
shares
Dec. 22, 2022
USD ($)
Jul. 21, 2022
USD ($)
Jun. 02, 2022
₪ / shares
Jun. 02, 2022
USD ($)
Dec. 28, 2016
USD ($)
Shareholders' Equity                      
Reverse share split, description   a reverse share split within a range of 1:2 to 1:12, to be effective at the ratio                  
Maximum number of authorized ordinary shares reverse share split   120,000,000                  
Issued and outstanding ordinary shares of reverse pre-split shares 60,100,000                    
Issued and outstanding ordinary shares of reverse post-split shares 8,600,000                    
Authorized number ordinary shares of reverse post-split shares 25,000,000                    
Number of share-based outstanding         4,723 4,723          
Per share value of stock repurchase authorized | ₪ / shares       ₪ 1.75   ₪ 1.75          
Treasury Stock, Common, Shares         574,658 574,658          
Minimum [Member]                      
Shareholders' Equity                      
Authorized number ordinary shares of reverse post-split shares 30,000,000                    
Maximum [Member]                      
Shareholders' Equity                      
Authorized number ordinary shares of reverse post-split shares 43,750,000                    
Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 [Member]                      
Shareholders' Equity                      
Number of warrants issued         534,300            
Proceeds from warrants | $   $ 4,675,125                  
Certain institutional purchasers [Member] | Registered direct offering of ordinary shares in July 2020 [Member]                      
Shareholders' Equity                      
Number of warrants issued         288,634            
Proceeds from warrants | $   3,556,976                  
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]                      
Shareholders' Equity                      
Number of warrants issued         514,010            
Proceeds from warrants | $   4,821,416                  
Placement agent [Member] | February 2020 best efforts offering [Member]                      
Shareholders' Equity                      
Number of warrants issued         32,880            
Proceeds from warrants | $   359,625                  
Placement agent [Member] | December 2020 private placement [Member]                      
Shareholders' Equity                      
Number of warrants issued         32,283            
Proceeds from warrants | $   $ 405,003                  
Kreos Capital V [Member]                      
Shareholders' Equity                      
Warrants grant date     Dec. 31, 2015                
Warrants exercisable, description.   currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of March 31, 2024.                  
Kreos Capital [Member]                      
Shareholders' Equity                      
Exercise price per share | $ / shares     $ 52.5                
Drawdown amount under loan agreement | $                     $ 8,000,000
Employee Stock Option [Member]                      
Shareholders' Equity                      
Award vesting period, description   Options to purchase ordinary shares generally vest over four years, with certain options to non-employee director                  
Shares reserved for future issuance (in shares)         145,560            
Unrecognized cost of shares | $         $ 2,300,000            
Expected term of shares   2 years 8 months 12 days                  
Restricted Stock Units (RSUs) [Member]                      
Shareholders' Equity                      
Weighted average grant date fair value, options (in USD per share) | $ / shares   $ 5.6                  
Restricted Stock Units (RSUs) [Member] | Nonemployee [Member]                      
Shareholders' Equity                      
Number of share-based outstanding         782            
Share repurchase program [Member]                      
Shareholders' Equity                      
Authorized value of stock repurchased | $             $ 5,800,000 $ 8,000,000   $ 8,000,000  
Per share value of stock repurchase authorized | ₪ / shares                 ₪ 0.25    
Treasury Stock, Common, Shares         574,658            
Total cost | $   $ 3,500,000